We're energized by the opportunity to be a key digital partner for India' - About Amazon India
Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast | Fierce Biotech
Amazon Web Services, Google, Microsoft cloud: How cloud services are boosting the pharma sector - BusinessToday - Issue Date: Apr 16, 2023
Novartis CEO Jimenez to step down early next year | The Seattle Times
Top Novartis lawyer steps down over Michael Cohen payments | Novartis | The Guardian
Agenda Contributors | World Economic Forum
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
Novartis digital chief is turning his CEO's 'unbossed' plans into new platforms | Fierce Pharma
Six Questions For Novartis CEO Narasimhan :: Scrip
Novartis Figuring Out How to Keep Brand Intact After Lobby Furor | IndustryWeek
Vas Narasimhan | LinkedIn
Global Health Challenges for Human Security (Studies in Global Equity): Chen, Lincoln C., Leaning M.D., Jennifer, Narasimhan, Vasant, Adams, Charles Darwin, Berlinguer, Giovanni, Bettcher, Douglas W., Bruderlein, Claude, Caballero-Anthony, Mely ...
Novartis says it knew of Zolgensma data problems before U.S. approval | The Japan Times
Novartis CEO's $50 Billion of Deals Was Just the First Act - Bloomberg
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
An Exciting Development, CRISPR Lets UW-Madison Researchers Edit Genes | Wisconsin Public Radio
We need short-term launches to keep driving growth: Novartis CEO - BusinessToday
Amazon.com: The Curious Advantage eBook : Ashcroft, Paul, Brown, Simon, Jones, Garrick: Kindle Store
New generation pushes AI boundaries - Nikkei Asia
Don't foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis - The Economic Times
Klaus Moosmayer, Ph.D. | Novartis
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
